NASDAQ: SYRS

Syros Pharmaceuticals Inc., (NASDAQ: SYRS) has disclosed in an SEC filing that Pfizer (NYSE: PFE) has decided to terminate a partnership previously established between Syros and Global Blood Therapeutics Inc., (GBT). Pfizer’s decision came after it acquired GBT for USD 5.4 billion in October 2022, taking over the existing deal.…